DOI:
10.1055/s-00000115
Suchttherapie
LinksClose Window
References
Novotna A, Mares J, Ratcliffe S et al.
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.
Eur J Neurol 2011;
18: 1122-1131
We do not assume any responsibility for the contents of the web pages of other providers.